Biotechnology
100 Most Popular
Most Popular Under $25

Sorrento Therapeutics

$9.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-0.53%) Today
+$0.11 (+1.17%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell SRNE and other stocks, options, ETFs, and crypto commission-free!

About SRNE

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. Read More The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.

CEO
Henry H. Ji
Employees
310
Headquarters
San Diego, California
Founded
2006
Market Cap
2.41B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
36.90M
High Today
$9.46
Low Today
$8.64
Open Price
$9.09
Volume
35.17M
52 Week High
$19.39
52 Week Low
$1.39

Collections

Biotechnology
100 Most Popular
Most Popular Under $25
Cancer Prevention
Biopharmaceutical
Therapy
Research And Development
Health

SRNE News

BenzingaSep 17

Sorrento Surges On FDA Nod For Initiating Clinical Study Of COVID-19 Antibody Treatment

Sorrento Therapeutics Inc (NASDAQ: SRNE) shares, which are known for being volatile, are headed higher Thursday morning. What Happened: The San Diego, Californ
BenzingaSep 14

Analyzing Sorrento Therapeutics's Unusual Options Activity

Sorrento Therapeutics (NASDAQ: SRNE) shares experienced unusual options activity on Monday. The stock price moved up to $6.67 following the option alert. Senti

SRNE Earnings

-$0.88
-$0.59
-$0.29
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Oct 2, Pre-Market

You May Also Like

HCCHU
FTLS
FT
TBBK
DUST
GGAL
NHICU
ORA
EVRG
FTXH
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.
Buy SRNE
Market Price
$9.54
Commissions
$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell SRNE stock and options commission-free.
LearnBlogCareersHelpLog InSign Up